Clinical Trial Update: Biological Effects of Quercetin in COPD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating biological effects of quercetin in chronic obstructive pulmonary disease; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Quercetin (quercetin)

Snippet

Sponsor: Temple University | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1, Phase 2 | Status: UNKNOWN